Cosmetic Products Notification Portal 1.5 update features new functions for Responsible Persons including product transfer and downloading capabilities.

Cosmetic Products Notification Portal 1.5 update features new functions for Responsible Persons including product transfer and downloading capabilities.
The burden of proof for EU compliance falls on manufacturers throughout all market segments. Learn more about your obligations from Obelis' EU regulatory team.
Read more on the Scientific Committee on Newly Identified Health Risks' opinion on the use of metal-on-metal health implants and their potential risks.
The Rapid Alert System (RAPEX) is an EU-wide vigilance platform for general products. Learn more about what it is and what it does with Obelis.
What is the compliance path for EMC & LVD products when trying to bring a wide range of products to the European market? Read on the compliance process here
Aix-en-Provence Court of Appeal in France clear Notified Body TÜV Rheinland of liability in PIP breast implant scandal case.
The European Court of Justice, by request of Germany's Federal Supreme Court, will clarify the liability of notified bodies in relation to medical devices.
The Council of the European Union has agreed on a general approach to new medical and in-vitro diagnostic device regulations to be finalized by the end of 2015.
From April 2016, low voltage directive 2006/95/EC will be repealed by the new 2014/35/EU LVD.
Explaining the difference between EU and FDA compliance under the new EU medical device regulation. Learn more about registration, notified bodies and more.